Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Suncor Energy Inc. (SU) Price & Performance

Charles River Laboratories Intl. IncTrade
Suncor Energy Inc.Trade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Suncor Energy Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $228.11 (market cap $11.14B), while Suncor Energy Inc. trades at $60.11 (market cap $71.44B). The key difference: Suncor Energy Inc. is far larger — about 6.4× Charles River Laboratories Intl. Inc's market cap, and Suncor Energy Inc. pays a 2.76% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

CRLSU
Market Cap
$11.14B$71.44B
Sector
HealthEnergy
52-Week High
$233.60$69.73
52-Week Low
$145.57$38.17
Enterprise Value
$14.00B$79.57B
Dividend Yield
2.76%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Suncor Energy Inc.

Suncor Energy (SU) trades at $61.27, up 3.41% with strong bullish momentum. The stock shows robust fundamentals with a P/E of 16.54, net margin of 11.62%, and consistent dividend payments. Recent earnings beat expectations in Q3 and Q4 2025, though Q1 2026 slightly missed. Technical indicators signal bullish sentiment with the current price near resistance at $62. Analyst consensus is strongly positive with 74% buy ratings.

SU presents a compelling investment case with attractive valuation metrics and strong profitability. However, investors face risks from oil price volatility and recent operational challenges. The company's disciplined capital allocation and record production support long-term value, but macroeconomic headwinds and competitive pressures require careful monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Suncor Energy Inc.

Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.

Read more on SU